The C49Y CARD11 variant has been reported in diffuse large B‐cell lymphoma and was identified in an unbiased screen for gain‐of‐function CARD11 mutants capable of activating NF‐κB and promoting human diffuse large B‐cell lymphoma tumor growth in vitro.46 This evidence concerns the gene NFKB1 and neoplasm.